THE APEX TIMES
The XLV portfolio reduced its exposure to Eli Lilly (LLY) and Johnson & Johnson (J&J) on Nov. 9, selling $320.2 million of stock and making no new additions on the day.
State Street’s Health Care Select Sector SPDR Fund, known as XLV, sold shares of Eli Lilly (LLY) and Johnson & Johnson (J&J) on Nov. 9, according to a market update published by Yahoo Finance. The transaction was part of a broader trimming of holdings within the fund’s healthcare sector basket.
In the Nov. 9 activity, XLV disposed of $320.2 million of stock tied to Eli Lilly and J&J and cut all 60 positions in the relevant sales package. The report also said the fund added nothing new during the same Monday session, indicating the day’s activity was focused on reducing existing exposure rather than reallocating into new positions.
The announcement did not describe the rationale behind the move, such as whether the sales were driven by valuation targets, portfolio rebalancing, risk controls, or changes to the fund’s benchmark weightings. It also did not specify whether the positions were reduced across multiple lots or entirely exited in a single set of trades.
Eli Lilly and Johnson & Johnson remain among the best-known healthcare companies tracked by sector-focused investors. For investors using large sector ETFs like XLV, changes in component holdings can announcement routine rebalancing or operational adjustments, though such moves are not always interpreted as a direct commentary on individual company fundamentals.
The update comes as healthcare ETFs continue to attract trading and long-term allocations based on the performance of broad drugmakers, medical technology firms, and diversified healthcare companies. Sector funds are designed to provide targeted exposure rather than thematic bets on a single product pipeline, so position changes can reflect index mechanics, weighting rules, and turnover decisions.
For Eli Lilly, which trades on the New York Stock Exchange under the ticker LLY, the Nov. 9 sale by XLV means the fund’s unit holders were temporarily less exposed to the stock following the transaction. However, the market update did not provide a breakdown of the share counts sold or the exact percentage of XLV’s total holdings that the exit represented.
Similarly, Johnson & Johnson was included in the trimming described in the update, but the report did not include the company-specific sale totals for each name in isolation. As a result, it is not possible to determine from the published post whether one stock contributed more to the $320.2 million figure than the other.
What is clear from the market update is the direction of the move: XLV reduced exposure by selling $320.2 million and cut all 60 positions mentioned in the sales package, while also reporting no new additions that day. What remains uncertain is why the fund acted at that specific time, and whether the change reflects routine portfolio maintenance or a broader shift in sector allocations.
A strong quarter from CoreWeave, a major cloud provider for AI compute, helped quiet worries that technology infrastructure spending could cool. Shares tied to AI chips and networking moved higher alongside the sentiment shift.
The ride-hailing and delivery platform is expanding an expanded McDonald’s partnership across 14 markets, positioning delivery growth as a lever for broader Uber Direct adoption and customer engagement.
A major downgrade cut Nvidia’s target price by about 60 percent, while other Wall Street analysts held bullish outlooks and pointed to higher upside targets.
A Bank of America analyst adjusted Eli Lilly’s price target, saying attention should broaden beyond the company’s weight-loss blockbuster franchise as it prepares for its December Innovation Day.
A new report says Tesla and SpaceX have each formed special committees to review a potential all-stock merger, a move that comes as Tesla prepares to unveil its next-generation Roadster.
A new report says Visa is integrating with Monad to expand the flexibility of its stablecoin settlement network, pointing to surging settlement activity and growing institutional interest in faster, programmable payment flows.
Bank of America sees upside in Qualcomm’s efforts to position the chipmaker as a broader supplier to AI data centers, while still expressing caution on what near-term execution can deliver.
A Wall Street note captured a split view of Advanced Micro Devices, with higher profit expectations offset by a lower price target amid recent market pressure.
A Yahoo Finance report says Cathie Wood’s ARK Investment Management reduced its Amazon position while adding to a basket of aerospace-related names after strong trading activity around a rocket launch company.
A recent pullback has renewed debate over whether Exxon Mobil’s valuation properly reflects its current deal slate, including new activity tied to Venezuela, despite the company’s strong multi-year run.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...